Business Context and Reporting Period
Company: Quantum Biopharma Ltd. (formerly FSD Pharma Inc.)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2024 (Filed August 26, 2024)
Principal Office: Toronto, Ontario, Canada
This filing discloses the execution of an Amended and Restated Exclusive Intellectual Property License Agreement dated August 14, 2024, involving the Company, Celly Nutrition Corp. (British Columbia and Delaware entities), and Lucid Psycheceuticals, Inc.
Key Financial Metrics
The filing text does not provide standard financial performance metrics such as revenue, profit, cash flow, operating margins, or liquidity ratios for the reporting period.
Debt and Loan Activity:
- The Company amended its loan to Celly Nutrition Corp. (Celly Nu).
- Loan Increase: CA$300,000.
- Total Loan Amount: CA$1,300,000.
- Security: An Amended and Restated General Security Agreement was executed by Celly Canada in favor of the Company on April 3, 2024.
Material Changes
The filing details significant amendments to the Original License Agreement dated July 31, 2023:
- New Licensee: Celly Nutrition Corp. (Delaware) ("Celly U.S.") was added as a licensee.
- Trademark Ownership: Confirmed that Celly Canada became the sole and exclusive owner of the "UNBUZZD" trademark pursuant to an IP Purchase Agreement dated October 2, 2023.
- Trademark Licensing: Celly Canada licensed the UNBUZZD trademark to Celly U.S. via an assignment agreement dated October 2, 2023.
- Loan Restructuring: The agreement references the Amended Loan Agreement increasing the loan principal to CA$1,300,000.
Guidance, Outlook, and Risks
Management Commentary: The filing serves as a disclosure of contractual amendments and does not contain forward-looking guidance, earnings outlook, or general management commentary regarding future operations.
Risks and Contingencies:
- The filing notes that descriptions of the agreements are not complete and are subject to the full terms of the attached exhibits.
- Reliance on the performance of licensees (Celly Canada, Celly U.S., and Lucid) regarding the UNBUZZD trademark and loan repayment.
Investor Verification Checklist
- Verify the full terms of the Amended and Restated Exclusive Intellectual Property License Agreement (Exhibit 4.1).
- Confirm the repayment schedule and interest terms of the CA$1,300,000 loan to Celly Nutrition Corp. (Exhibit 4.3).
- Review the Amended and Restated General Security Agreement (Exhibit 4.4) to understand collateral securing the loan.
- Assess the commercial viability of the UNBUZZD trademark under the new licensing structure involving Celly U.S.